Aligning Market Access Strategies with the WHO’...

By Rene Pretorius

May 28, 2025

On May 27, 2025, the World Health Organization (WHO) adopted a historic resolution—Promoting and prioritising an integrated approach to lung health—at the World He...
South Africa Health Reform: A Critical Examination of Universal Coverage Prop...
EU Establishes Expert Panel for Orphan Paediatric Devices
Another GLP-1 Drug Access Model: Will a Co-Pay Cap Revolutionize Affordability?
High Orphan Drug Prices Persist Despite Market Exclusivity Expiration
The Impact of MFN Pricing on the U.S. Biosimilar Market
Navigating EU AI Act Healthcare Compliance: Proactive Steps for Ethical AI In...
Hepatitis Vaccine Uptake: Trends, Challenges, and the Role of Pharmacists
Biosimilars Price Competition: Impact on U.S. Pharmaceutical Pricing and Mark...
MFN Drug Pricing Targets: Lowering U.S. Drug Costs Through International Alig...
HTA Reform Analysis: Patterns and Global Trends in Health Technology Assessment
Drug Pricing Analysis: ICER’s Launch Price and Access Report Aims to En...
Trends in Anticancer Drug Pricing: Analyzing Medicare Launch Prices and Impac...